WhizAI

About WhizAI

WhizAI offers an AI-powered analytics platform specifically designed for life sciences, utilizing proprietary natural language processing (NLP) and domain-tuned large language models (LLMs) to deliver precise, actionable insights from complex data queries. This technology enables commercial teams to access real-time analytics without the need for traditional reporting tools, enhancing decision-making speed and accuracy in clinical research and drug commercialization.

```xml <problem> Life sciences companies struggle to extract actionable insights from complex data using traditional business intelligence tools, requiring specialized skills and time-consuming report generation. This delays critical decision-making in areas such as clinical research, drug commercialization, and patient services. </problem> <solution> WhizAI provides a conversational analytics platform powered by proprietary natural language processing (NLP) and domain-tuned large language models (LLMs) designed specifically for the life sciences industry. The platform enables users to interact with data using natural language, generating real-time, precise insights without the need for SQL queries or pre-built dashboards. By understanding the nuances of life sciences data, WhizAI delivers accurate and contextual analysis, accelerating decision-making for commercial teams, clinical researchers, and IT leaders. The platform integrates seamlessly with existing software like Veeva, Microsoft Teams, and Salesforce, making insights accessible across various devices and locations. </solution> <features> - Conversational interface for querying data using natural language - Proprietary NLP engine and domain-tuned LLMs for accurate interpretation of life sciences data - Real-time insights and automated notifications for timely decision-making - Integration with Veeva, Microsoft Teams, Salesforce, and other platforms - Role-based access control and data privacy measures to ensure data security - Ability to build and deploy dashboards in under 30 minutes - Knowledge graphs to identify anomalies, reveal trends, and compare key drivers - Semantic, Domain, Data, and Knowledge Models to reduce hallucinations </features> <target_audience> WhizAI targets business users, analysts, data science teams, and IT leaders within pharmaceutical, biotechnology, medical device, and other life sciences organizations. </target_audience> <revenue_model> WhizAI reduces Total Cost of Ownership (TCO) by 50% by cutting support, development, and infrastructure costs. </revenue_model> ```

What does WhizAI do?

WhizAI offers an AI-powered analytics platform specifically designed for life sciences, utilizing proprietary natural language processing (NLP) and domain-tuned large language models (LLMs) to deliver precise, actionable insights from complex data queries. This technology enables commercial teams to access real-time analytics without the need for traditional reporting tools, enhancing decision-making speed and accuracy in clinical research and drug commercialization.

Where is WhizAI located?

WhizAI is based in Somerset, United States.

When was WhizAI founded?

WhizAI was founded in 2017.

How much funding has WhizAI raised?

WhizAI has raised 20320000.

Location
Somerset, United States
Founded
2017
Funding
20320000
Employees
85 employees
Major Investors
Shanda Group, Cencora

Find Investable Startups and Competitors

Search thousands of startups using natural language

WhizAI

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

WhizAI offers an AI-powered analytics platform specifically designed for life sciences, utilizing proprietary natural language processing (NLP) and domain-tuned large language models (LLMs) to deliver precise, actionable insights from complex data queries. This technology enables commercial teams to access real-time analytics without the need for traditional reporting tools, enhancing decision-making speed and accuracy in clinical research and drug commercialization.

whiz.ai7K+
cb
Crunchbase
Founded 2017Somerset, United States

Funding

$

Estimated Funding

$20M+

Major Investors

Shanda Group, Cencora

Team (75+)

No team information available.

Company Description

Problem

Life sciences companies struggle to extract actionable insights from complex data using traditional business intelligence tools, requiring specialized skills and time-consuming report generation. This delays critical decision-making in areas such as clinical research, drug commercialization, and patient services.

Solution

WhizAI provides a conversational analytics platform powered by proprietary natural language processing (NLP) and domain-tuned large language models (LLMs) designed specifically for the life sciences industry. The platform enables users to interact with data using natural language, generating real-time, precise insights without the need for SQL queries or pre-built dashboards. By understanding the nuances of life sciences data, WhizAI delivers accurate and contextual analysis, accelerating decision-making for commercial teams, clinical researchers, and IT leaders. The platform integrates seamlessly with existing software like Veeva, Microsoft Teams, and Salesforce, making insights accessible across various devices and locations.

Features

Conversational interface for querying data using natural language

Proprietary NLP engine and domain-tuned LLMs for accurate interpretation of life sciences data

Real-time insights and automated notifications for timely decision-making

Integration with Veeva, Microsoft Teams, Salesforce, and other platforms

Role-based access control and data privacy measures to ensure data security

Ability to build and deploy dashboards in under 30 minutes

Knowledge graphs to identify anomalies, reveal trends, and compare key drivers

Semantic, Domain, Data, and Knowledge Models to reduce hallucinations

Target Audience

WhizAI targets business users, analysts, data science teams, and IT leaders within pharmaceutical, biotechnology, medical device, and other life sciences organizations.

Revenue Model

WhizAI reduces Total Cost of Ownership (TCO) by 50% by cutting support, development, and infrastructure costs.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.